Stock A000020 DONGWHA PHARM.CO.,LTD
Add to a list
To use this feature you must be a member
Log inSign up

News Dongwha Pharm.Co.,Ltd

Equities

A000020

KR7000020008

End-of-day quote Korea S.E.
Other stock markets
 06:00:00 2024-04-28 pm EDT 		5-day change 1st Jan Change
8,750 KRW +0.57% Intraday chart for Dongwha Pharm.Co.,Ltd +0.57% -14.80%
2023 Cong Ty Co Phan Tscare announced that it has received KRW 37.442505601 billion in funding from Dongwha Pharm.Co.,Ltd CI
2023 Oncocross Co., Ltd. announced that it has received KRW 15.00002592 billion in funding from InterVest Co., Ltd., Dongwha Pharm.Co.,Ltd and other investors CI

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Cong Ty Co Phan Tscare announced that it has received KRW 37.442505601 billion in funding from Dongwha Pharm.Co.,Ltd
CI
Oncocross Co., Ltd. announced that it has received KRW 15.00002592 billion in funding from InterVest Co., Ltd., Dongwha Pharm.Co.,Ltd and other investors
CI
Oncocross Co., Ltd. announced that it expects to receive KRW 15.00002592 billion in funding from InterVest Co., Ltd., Dongwha Pharm.Co.,Ltd and other investors.
CI
Dongwha Pharm.Co.,Ltd signed an agreement to acquire 51% stake in TRUNGSONCARE CO., LTD for $30 million.
CI
Cong Ty Co Phan Tscare announced that it expects to receive KRW 39.115606503 billion in funding from Dongwha Pharm.Co.,Ltd
CI
Dongwha Pharm.Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2023
CI
Dongwha Pharm.Co.,Ltd agreed to acquire additional 11.18% stake in MEDYSSEY Co.,Ltd for KRW 4 billion.
CI
Dongwha Pharm.Co.,Ltd completed the acquisition of 53.3% stake in MEDYSSEY Co.,Ltd from Jongwook Jang, Min-kyung Jang, Ho-jeong Kim, Ji-won Jang and Seon-ok Kim.
CI
Dongwha Pharm.Co.,Ltd agreed to acquire 53.3% stake in MEDYSSEY Co.,Ltd from Jongwook Jang, Min-kyung Jang, Ho-jeong Kim, Ji-won Jang and Seon-ok Kim for KRW 19.6 billion.
CI
Philosys Co., Ltd. announced that it has received KRW 4 billion in funding from Dongwha Pharm.Co.,Ltd
CI
Philosys Co., Ltd. announced that it expects to receive KRW 4 billion in funding from Dongwha Pharm.Co.,Ltd
CI
Tranche Update on Dongwha Pharm.Co.,Ltd's Equity Buyback Plan announced on July 20, 2017.
CI
Dongwha Pharm.Co.,Ltd's Equity Buyback announced on July 20, 2017 has closed with 100,000 shares, representing 0.36% for KRW 875.76 million.
CI
Dongwha Pharm.Co.,Ltd announces an Equity Buyback for 100,000 shares.
CI
Dongwha Pharm.Co.,Ltd authorizes a Buyback Plan.
CI
Tranche Update on Dongwha Pharm Co.,Ltd.'s Equity Buyback Plan announced on January 30, 2015.
CI
Tranche Update on Dongwha Pharm Co.,Ltd.'s Equity Buyback Plan announced on January 30, 2015.
CI
Dongwha Pharm Co.,Ltd.’s Equity Buyback announced on January 30, 2015 has closed with 320,000 shares, representing 1.15% for KRW 2,349.54 million.
CI
Dongwha Pharm Co.,Ltd. announces an Equity Buyback for 320,000 shares.
CI
Dongwha Pharm Co.,Ltd. authorizes a Buyback Plan.
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. A000020 Stock
  4. News Dongwha Pharm.Co.,Ltd